Rigel Pharma (RIGL) Reports In-Line Q1 Loss
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $35.61 --0%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q1 EPS of ($0.19), in-line with the analyst estimate of ($0.19). Revenue for the quarter came in at $5 million versus the consensus estimate of $4 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Archrock names Mohit Singh as CFO, effective July 6
- EXL to acquire iMerit in deal valued at up to $310 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
